Roby Joyce - Sep 18, 2023 Form 3 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Director
Signature
/s/ Roby Joyce, M.D.
Stock symbol
BIAF
Transactions as of
Sep 18, 2023
Transactions value $
$0
Form type
3
Date filed
9/26/2023, 04:42 PM
Next filing
Jan 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIAF Common Stock 583K Sep 18, 2023 The Joyce Living Trust F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIAF Warrant Sep 18, 2023 Common Stock 5.71K $5.25 The Joyce Living Trust F2
holding BIAF Warrant Sep 18, 2023 Common Stock 14.3K $5.25 The Joyce Living Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes: (i) 18,158 shares of common stock issued to The Joyce Living Trust on September 6, 2022 and (ii) 564,972 shares of restricted common stock that were granted on September 18, 2023, in connection with an Asset Purchase Agreement between bioAffinity Technologies, Inc. and Village Oaks Pathology Services, P.A., of which Dr. Joyce is the principal and owner.
F2 Dr. Joyce is the co-Trustee of The Joyce Living Trust (the "Trust"), together with his wife, Joyce M. Joyce, each of whom may act unilaterally with regard to voting and disposition power with respect to the shares owned by the Trust. Dr. Joyce and Mrs. Joyce are the beneficiaries of the Trust.

Remarks:

Exhibit List - Exhibit 24.1: Power of Attorney (Roby Joyce)